In our study, the expression level of MMP9 was significantly increased in the MI group, further validating its critical role in the occurrence and progression of MI, which offered potential clinical applications for therapeutic strategies targeting MMP9 and might open new avenues for intervention and treatment of cardiovascular diseases. This evidence concerns the gene MMP9 and cardiovascular disorder.